- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: estrogen gene
Total 271751 results
-
University of CagliariNot yet recruitingQuality of Life | Endometriosis | AmenorrheaItaly
-
Mansoura UniversityRecruiting
-
Peking Union Medical College HospitalNot yet recruitingBreast Cancer | Chemotherapy Induced Amenorrhea | Ovarian Function SuppressionChina
-
University of Maryland, BaltimoreRecruitingBreast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Pamela MoalliEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ ProlapseUnited States
-
Galaxy Pharma (Pvt) LimitedOva IVF & Reproductive Health Clinics, KarachiRecruitingSecondary Infertility | Primary Infertility | Low Responders | Mild to Moderate Male Factor InfertilityPakistan
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
National Institute of Mental Health (NIMH)Recruiting
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian CancerUnited States, Korea, Republic of, France, Germany, Spain, Italy, Canada, Russian Federation, United Kingdom, Turkey, Australia, Czechia, Switzerland
-
National Cancer Institute (NCI)NRG OncologySuspendedAdult Ovarian Granulosa Cell TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEdema | Erythema | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast Carcinoma | Peau d'OrangeUnited States
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBack Pain | Irritable Bowel Syndrome | Endometriosis | Interstitial Cystitis | Chronic Fatigue Syndrome | Temporomandibular Disorder | Fibromyalgia Syndrome | Vestibulodynia | Migraines | Tension HeadacheUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Mayo ClinicNational Cancer Institute (NCI)Enrolling by invitationAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Advanced Triple-Negative Breast CarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
MedSIRNovartisActive, not recruiting
-
Eli Lilly and CompanyActive, not recruitingBreast NeoplasmsUnited States, Spain, Germany, Taiwan, Canada, Japan, Australia, Belgium, Denmark, France, Finland, Mexico, Italy, Korea, Republic of, Poland, Russian Federation, Switzerland, Puerto Rico, Romania, Greece
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
-
Prasco LLCCompletedVulvar and Vaginal AtrophyUnited States
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High AmplificationItaly, United States, France, United Kingdom, Spain, Portugal, Canada
-
Eli Lilly and CompanyActive, not recruitingNeoplasm Metastasis | Breast NeoplasmUnited States, Hungary, Italy, Czechia, Taiwan, Turkey, Belgium, Spain, Korea, Republic of, Israel, Argentina, Greece, France, Mexico, Sweden, Denmark, Poland
-
Organon and CoCompleted
-
Zagazig UniversityCompleted
-
Frederic AmantKom Op Tegen Kanker; Research Foundation FlandersCompletedEndometrial Cancer | Endometrial Stromal Sarcoma | Sex Cord Stromal Tumor | Adenosarcoma of Uterus | Leiomyosarcoma Uterus | Serous Ovarian TumorBelgium, Netherlands
-
Organon and CoTerminatedModerate to Severe Primary Dysmenorrhea
-
Xuanzhu Biopharmaceutical Co., Ltd.Active, not recruitingAdvanced Breast CancerChina
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingBreast Neoplasm FemaleAustralia
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Bilateral Breast Carcinoma | Localized Breast CarcinomaUnited States
-
PfizerArvinas Estrogen Receptor, Inc.Completed
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Korea, Republic of, United Kingdom, Australia, Belgium, China, Denmark, France, Hungary, Portugal, Spain, Taiwan, Thailand, Canada, Italy, Argentina, Brazil, Poland, Singapore, Germany, Greece, Hong Kong, Ukraine, Russian... and more
-
Novartis PharmaceuticalsActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v6United States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical HyperplasiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditionsUnited States
-
Organon and CoTerminatedContraceptionSouth Africa, Austria, Costa Rica, Denmark, Finland, Germany, Hungary, Italy, Mexico, Netherlands, Norway, Peru, Poland, Sweden
-
National Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Alexion Pharmaceuticals, Inc.Completed
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
Menarini GroupCompletedAdvanced or Metastatic Breast CancerSpain, Belgium, United Kingdom, France, United States, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisActive, not recruiting
-
Mayo ClinicUniversity of California, San FranciscoTerminated